Cost, scale, and subtle differences in structure set these two tech ETFs apart for investors weighing sector exposure options.

Stephen Wright outlines an opportunity for investors with £20,000 in excess cash to target a £1,450 a year second income in ...

Novo Nordisk gained a head start in the GLP-1 race but then fell behind; Pfizer is working hard to catch up to the new leader.

Taylor Wimpey’s recent dividend record has been outstanding, but investors thinking of buying shares need to take a careful look beneath the surface. The post Is a 9% yield from one of the UK’s most ...

With its share price falling by more than half since December 2024, James Beard considers the prospects for the worst-performing member of the FTSE 250. The post Is it time to consider buying this ...

Discover some of the best-performing FTSE shares of 2025, and which ones expert analysts think will outperform in 2026 and beyond. The post 2 FTSE shares experts think will smash the market in 2026!

Anyone who had the courage to buy Rolls-Royce shares three years ago, and has held on to them, has made a life-changing amount of money. The post £2,000 invested in Rolls-Royce shares 3 years ago is ...

This FTSE 250 stock looks like a rare and outstanding passive income opportunity. But is the 12.5% dividend yield too good to be true? The post 12.5% dividend yield! Could buying this FTSE 250 stock ...

Starting off with just a few quid a week, one can build potent passive income over time. I've already done this, but what does ChatGPT think? The post Building powerful passive income from just £20 a ...

These companies should have no trouble continuing to increase their dividends in 2026.

Vanguard has announced the final distribution for VTS ETF investors. The post Own VTS ETF? Here's your next dividend appeared first on The Motley Fool Australia.

By focusing on ETFs that emphasize low cost, diversification, and growth potential, the title of "millionaire" isn't out of reach.